Substantial doubt about the company's ability to continue as a going concern.
“The working capital deficit and the expectation of significant future costs raises substantial doubt about the Company's ability to continue as a going concern within one year after the date that the accompanying unaudited condensed consolidated financial statements are issued. Additionally, Management has determined that the mandatory liquidation and subsequent dissolution, should the Company be unable to complete a Business Combination by the end of the Combination Period, raises substantial doubt about the Company's ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after December 20, 2026. Management plans to address this uncertainty through the closing of its proposed Business Combination. There is no assurance that the Company's plans to consummate a Business Combination will be successful within the Combination Period. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 13, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The closing range uses available history since Jul 23, 2026; less than a full year is stored.
Melar Acquisition Corp. I shareholders approved the Business Combination with Everli Global Inc. on October 22, 2026; after 3,852,564 share redemptions, approximately $0.8 million will remain in the Trust Account. Completion is expected promptly after satisfaction or waiver of conditions.
Melar Acquisition Corp. I’s registration statement for its proposed combination with Everli Global Inc. became effective on October 2, 2026, and definitive proxy materials were mailed to shareholders of record on September 28, 2026 for an extraordinary general meeting.
Melar Acquisition Corp. I announced the SEC declared its Form S-4 effective on October 2, 2026, advancing the Everli business combination. Shareholders will vote October 22, 2026, and closing is expected to create Nasdaq-listed Everli Global Holdings Inc.
Melar seeks shareholder approval on October 22, 2026 to combine with Everli, providing Everli holders $180,000,000 of New Melar common stock plus converted bridge financing proceeds and any equity investment, with each share valued at $10.00.
Melar entered into a merger agreement with Everli Global Inc. under which Everli shareholders receive New Melar common stock valued at $180,000,000, plus converted bridge financing proceeds and any Everli equity investment.
Illustrative technical + ownership context — a signal mix, not investment advice.
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MACIW
this stock
Melar Acquisition Corp. I
|
$66.15M | — | — | — | — |
|
VYLR
Vylor Inc.
|
$46.80B | — | — | — | 2.2% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$650.38M | +3.1% | — | — | 0.0% |
|
CCXI
Churchill Capital Corp XI
|
$627.18M | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Melar Acquisition Corp. I shareholders approved the Business Combination with Everli Global Inc. on October 22, 2026; after 3,852,564 share redemptions, approximately $0.8 million will remain in the Trust Account. Completion is expected promptly after satisfaction or waiver of conditions.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MACIW | -33.2% | -61.5% | — | -4.0% | — |
| SPY | -0.7% | -1.3% | +2.5% | +1.5% | +12.5% |
| vs SPY | -32.5% | -60.1% | — | -5.5% | — |
